Table 3. Multiple linear regression analysis expressing independent predictors of fasting glucagon in Group A, Group B, and Group C.

*p-Value ≤0.05 is taken as significant.

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure

Group A: Patients with normal glucose tolerance.

Group B: Patients with impaired glucose tolerance.

Group C: Patients with type 2 diabetes.

Studied groups	Clinical variables	Standardized coefficients (β)	p-Value
Group A	SBP	0.391	0.033*
	Hip circumference	0.421	0.021*
Group B	Two-hour plasma glucose	0.421	0.021*
	BMI	0.383	0.051*
	Hip circumference	0.483	0.012*
Group C	Two-hour plasma glucose	0.470	0.041*
	SBP	0.441	0.051*
	DBP	0.446	0.052*
	BMI	0.387	0.05*
	Waist circumference	0.370	0.047*
	Hip circumference	0.521	0.022*
	Waist-to-hip ratio	0.472	0.031*